Evidence map›Paper›PMID 41088245›Full record

ArticleJournal of inflammation (London, England)2025

Glutaminase activity maintains NK cell cytotoxicity through metabolic regulation of effector function.

M Jedlička, T Feglarová, V Švubová, E Mašínová, V Graman, K Kuglerová, J Szabová, F Jahan, M Korhonen, K Kuželová and 2 more

Abstract read
In one paragraph

Article in Journal of inflammation (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M JedličkaInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
T FeglarováInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
V ŠvubováInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
E MašínováInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
V GramanInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
K KuglerováInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
J SzabováInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
F JahanFinnish Red Cross Blood Service, Research and Development, Biomedicum, Haartmaninkatu 8, Helsinki, 00290, Finland.
M KorhonenFinnish Red Cross Blood Service, Research and Development, Biomedicum, Haartmaninkatu 8, Helsinki, 00290, Finland.
K KuželováInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia.
M Hortová-KohoutkováInternational Clinical Research Center of St. Anne's University Hospital in Brno (FNUSA-ICRC), Pekařská 53, Brno, 656 91, Czechia. marcela.hortova@fnusa.cz.
J FričInstitute of Hematology and Blood Transfusion, U Nemocnice 1, Prague 2, 128 00, Czechia. jan.fric@uhkt.cz.

Funding

European Regional Development Fund/state budget of the Czech Republic AIIHHP: CZ.02.1.01/0.0/0.0/16_025/0007428, OP RDE, MEYSInstitute of Hematology and Blood Transfusion IHBT, 00023736Ministry of Health of the Czech Republic NU22-08-00287
6 · The paper itself

Abstract

backgroundNatural killer (NK) cells are responsible for monitoring and eliminating malignant or virus-infected cells. To become activated, NK cells must upregulate oxidative phosphorylation and glycolysis to meet the high energetic demands associated with cytotoxic and effector functions. While glutamine can also fuel the tricarboxylic acid cycle through its conversion to alpha-ketoglutarate, the precise role of this pathway in NK-cell cytotoxic activity is unclear.

resultsTo investigate NK-cell dependency on glutamine, we selectively inhibited kidney-type glutaminase to prevent glutamine metabolism. We analysed the metabolism and cytotoxicity of expanded primary NK cells, treated or not with glutaminase inhibitor. Glutaminase inhibition significantly reduced oxidative phosphorylation and led to a significant decrease in NK cell cytotoxic function. Furthermore, glutaminase inhibition reduced protein synthesis in activated NK cells. Meanwhile, supplementation with alpha-ketoglutarate rescued both the metabolic and cytotoxic capacities of primary expanded NK cells.

conclusionsOur findings highlight the importance of glutaminase activity in supporting NK cell respiratory metabolism and cytotoxic function, and the need for caution when combining glutaminase inhibitors with NK cell-based therapies.

Indexed as

Alpha-ketoglutarateCell cytotoxicityGlutaminaseImmunometabolismNatural killer cell

Identifiers

PMID41088245
PMCPMC12523120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.